I) (Transdermales Pflaster): rivastigminum 51.84 mg, E 307, 2-ethylhexylis acrylatis et vinylis acetatis polymerisatum, butylis methacrylatis et methylis methacrylatis polymerisatum, polyisobutylenum, polybutylenum, Trägermaterial: poly(ethylenis terephthalas), polyethylenum, Drucktinte: Blau, ad praeparationem pro 21.6 cm², cum liberatione 9.5 mg/24h.
II) (Abdeckpflaster): acrylates et vinylis acetatis polymerisatum, Trägermaterial: polyesterum, ad praeparationem pro 46.7 cm².
Packungsbestandteile
I
Transdermal patch
Active Agent
Dose
(Transdermales Pflaster): Rivastigminum
51.84 mg
Inactive agents
Dose
additional_information
2-ethylhexylis Acrylatis
Ad Praeparationem
21.6 cm
Blau
Drucktinte
Butylis Methacrylatis
Cum Liberatione
9.5mg / 24h
E 307
Methylis Methacrylatis Polymerisatum
Poly(Ethylenis Terephthalas)
Trägermaterial
Polybutylenum
Polyethylen
Polyisobutylenum
Vinylis Acetatis Polymerisatum
II
Transdermal patch
Inactive agents
Dose
additional_information
(Abdeckpflaster): Acrylates
Ad Praeparationem
46.7 cm
Polyesterum
Trägermaterial
Vinylis Acetatis Polymerisatum
Source
Data was imported : 07.03.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
